Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-463539
Filing Date
2012-11-09
Accepted
2012-11-09 16:53:09
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398261d10q.htm 10-Q 645856
2 EX-31.1 d398261dex311.htm EX-31.1 6940
3 EX-31.2 d398261dex312.htm EX-31.2 6944
4 EX-32.1 d398261dex321.htm EX-32.1 3280
5 EX-32.2 d398261dex322.htm EX-32.2 3290
  Complete submission text file 0001193125-12-463539.txt   5119425

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imuc-20120930.xml EX-101.INS 558196
7 XBRL TAXONOMY EXTENSION SCHEMA imuc-20120930.xsd EX-101.SCH 52665
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20120930_cal.xml EX-101.CAL 40582
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20120930_def.xml EX-101.DEF 153352
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20120930_lab.xml EX-101.LAB 376693
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20120930_pre.xml EX-101.PRE 256188
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 121194355
SIC: 2834 Pharmaceutical Preparations